Breaking News Instant updates and real-time market news.

2020-03-17 10:34:07 FCX Freeport McMoRan $5.94 / -0.3 (-4.81%) 10:34 03/17/20 03/17 10:34 03/17/20 10:34	Freeport McMoRan says Cerro Verde temporarily shifts to care, maintenance status Freeport-McMoRan announced that the Peruvian Government has issued a Supreme Decree and declaration of a National Emergency in its efforts to contain the outbreak of COVID-19. To comply with the Government's requirements, Cerro Verde has temporarily transitioned to a care and maintenance status for a 15-day period which commenced on March 16, 2020. During this period, onsite personnel will be limited to critical activities necessary to maintain the facilities pending a return to normal operations. Freeport-McMoRan owns 53.56% of Cerro Verde, which operates one of the world's largest concentrating facilities near Arequipa, Peru. In 2019, Cerro Verde produced 1.0 billion pounds of copper and 29 million pounds of molybdenum. Cerro Verde will work closely with Government authorities to be prepared to restart operations as soon as possible.
FCX Freeport McMoRan $5.94 / -0.3 (-4.81%) 02/18/20 Morgan Stanley Morgan Stanley downgrades Southern Copper to Underweight, prefers Freeport 01/14/20 Fly Intel: Top five analyst downgrades 01/14/20 Credit Suisse Freeport McMoRan downgraded to Underperform from Neutral at Credit Suisse 12/19/19 Goldman Sachs Freeport best positioned for higher cooper prices, says Goldman Sachs

2020-03-17 10:34:07

FCX

Freeport McMoRan

$5.94 / -0.3 (-4.81%)

10:34

03/17/20

03/17

10:34

03/17/20

10:34

Freeport McMoRan says Cerro Verde temporarily shifts to care, maintenance status

Freeport-McMoRan announced that the Peruvian Government has issued a Supreme Decree and declaration of a National Emergency in its efforts to contain the outbreak of COVID-19. To comply with the Government's requirements, Cerro Verde has temporarily transitioned to a care and maintenance status for a 15-day period which commenced on March 16, 2020. During this period, onsite personnel will be limited to critical activities necessary to maintain the facilities pending a return to normal operations. Freeport-McMoRan owns 53.56% of Cerro Verde, which operates one of the world's largest concentrating facilities near Arequipa, Peru. In 2019, Cerro Verde produced 1.0 billion pounds of copper and 29 million pounds of molybdenum. Cerro Verde will work closely with Government authorities to be prepared to restart operations as soon as possible.

FCX Freeport McMoRan

$5.94 / -0.3 (-4.81%)

02/18/20 Morgan Stanley: Morgan Stanley downgrades Southern Copper to Underweight, prefers Freeport

01/14/20: Fly Intel: Top five analyst downgrades

01/14/20 Credit Suisse: Freeport McMoRan downgraded to Underperform from Neutral at Credit Suisse

12/19/19 Goldman Sachs: Freeport best positioned for higher cooper prices, says Goldman Sachs

TODAY'S FREE FLY STORIES

Hot Stocks	Dada Nexus works with retailers to provide delivery service in Shijiazhuang » 05:42 01/25/21 01/25 05:42 01/25/21 05:42 DADA Dada Nexus $44.93 / +1.96 (+4.56%) Dada Group announced it… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options DADA Dada Nexus $44.93 / +1.96 (+4.56%) 01/15/21 Dada Nexus announces JD Daojia partners with over 20 regional supermarkets 01/12/21 Aurora Mobile partners with Dada Now on user experience, account security 12/21/20 Dada Nexus, Unilever announce new strategic partnership 12/14/20 Dada Group announces delivery partnership with JD.com, Innisfree DADA Dada Nexus $44.93 / +1.96 (+4.56%) 01/18/21 CICC Dada Nexus initiated with an Outperform at CICC 01/07/21 KeyBanc Dada Nexus initiated with an Overweight at KeyBanc 12/08/20 Fly Intel: Top five analyst downgrades 12/08/20 Morgan Stanley Dada Nexus downgraded to Equal Weight on competition risk at Morgan Stanley DADA Dada Nexus $44.93 / +1.96 (+4.56%) 11/19/20 Dada Nexus sees Q4 revenue RMB2B-RMB2.1B 11/19/20 Dada Nexus reports Q3 adjusted EPS RMB0.36 vs RMB1.71 last year 08/24/20 Dada Nexus sees Q3 revenue RMB 1.28B-1.34B, up 82% to 91% from last year 08/24/20 Dada Nexus reports Q2 EPS (11c), one estimate (18c) 03 Dec 05 Jun DADA Dada Nexus $44.93 / +1.96 (+4.56%) 11/30/20 Fly Intel: After-Hours Movers DADA Dada Nexus $44.93 / +1.96 (+4.56%) 12/23/20 new option listings and one option delisting on December 23rd
Downgrade	US Foods downgraded to Neutral from Overweight at JPMorgan » 05:39 01/25/21 01/25 05:39 01/25/21 05:39 USFD US Foods $34.76 / -0.58 (-1.64%) JPMorgan analyst John… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events USFD US Foods $34.76 / -0.58 (-1.64%) 01/19/21 US Foods awarded $390M Defense Logistics Agency contract for food distribution 01/08/21 US Foods awarded maximum $377.79M Defense Logistics Agency contract 11/02/20 US Foods is not providing guidance 10/16/20 US Foods announces Bill Hancock as chief supply chain officer USFD US Foods $34.76 / -0.58 (-1.64%) 12/14/20 JPMorgan US Foods price target raised to $35 from $30 at JPMorgan 12/02/20 Barclays US Foods price target raised to $27 from $25 at Barclays 11/10/20 BMO Capital US Foods upgraded to Outperform from Market Perform at BMO Capital 10/20/20 JPMorgan US Foods price target raised to $30 from $26 at JPMorgan USFD US Foods $34.76 / -0.58 (-1.64%) 11/02/20 US Foods reports Q3 adjusted EPS 15c, consensus 17c 08/04/20 US Foods not providing new fiscal 2020 financial guidance 08/04/20 US Foods reports Q2 adjusted EPS (25c), consensus (35c) USFD US Foods $34.76 / -0.58 (-1.64%) 11/02/20 Fly Intel: Pre-market Movers 02/16/21 US Foods - USFD
Downgrade	Planet Fitness downgraded to Neutral from Overweight at JPMorgan » 05:38 01/25/21 01/25 05:38 01/25/21 05:38 PLNT Planet Fitness $79.42 / -1.55 (-1.91%) JPMorgan analyst John… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options PLNT Planet Fitness $79.42 / -1.55 (-1.91%) 01/05/21 Planet Fitness CEO: I'm pretty happy with how things are going 12/29/20 Planet Fitness announces special offer for $0 enrollment, $10 a month 12/16/20 Planet Fitness names Bill Bode as new COO 08/18/20 Planet Fitness CEO says 1,500 of 2,000 gyms are now open PLNT Planet Fitness $79.42 / -1.55 (-1.91%) 01/12/21 Cowen Planet Fitness price target raised to $90 from $73 at Cowen 01/12/21 Piper Sandler Planet Fitness price target raised to $90 from $81 at Piper Sandler 12/14/20 BMO Capital Planet Fitness price target raised to $80 from $70 at BMO Capital 11/12/20 Exane BNP Paribas Planet Fitness initiated with an Underperform at Exane BNP Paribas PLNT Planet Fitness $79.42 / -1.55 (-1.91%) 11/05/20 Planet Fitness not providing FY20 guidance 11/05/20 Planet Fitness reports Q3 adjusted EPS 2c, consensus 12c 11/05/20 Notable companies reporting after market close 08/04/20 Planet Fitness reports Q2 EPS (32c), consensus (16c) PLNT Planet Fitness $79.42 / -1.55 (-1.91%) 12/15/20 Planet Fitness lower after WSJ columnist recommends taking profits PLNT Planet Fitness $79.42 / -1.55 (-1.91%) 11/05/20 Fly Intel: After-Hours Movers PLNT Planet Fitness $79.42 / -1.55 (-1.91%) 12/29/20 Unusual call flow in option market yesterday 12/28/20 Healthy profits for call spread collar trader in Planet Fitness 12/09/20 Planet Fitness call volume above normal and directionally bullish 12/09/20 Unusually active option classes on open December 9th
Downgrade	Texas Roadhouse downgraded to Underweight from Neutral at JPMorgan » 05:38 01/25/21 01/25 05:38 01/25/21 05:38 TXRH Texas Roadhouse $79.67 / +1.33 (+1.70%) JPMorgan analyst John… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events TXRH Texas Roadhouse $79.67 / +1.33 (+1.70%) 10/28/20 Texas Roadhouse reports Q3 comparable restaurant sales decline of 6.3% 08/03/20 Texas Roadhouse says July period SSS decreased 13.0% TXRH Texas Roadhouse $79.67 / +1.33 (+1.70%) 01/19/21 Goldman Sachs Texas Roadhouse initiated with a Neutral at Goldman Sachs 01/11/21 Evercore ISI Texas Roadhouse downgraded to In Line on valuation at Evercore ISI 01/11/21 Evercore ISI Texas Roadhouse downgraded to In Line from Outperform at Evercore ISI 01/05/21 Fly Intel: Top five analyst initiations TXRH Texas Roadhouse $79.67 / +1.33 (+1.70%) 10/28/20 Texas Roadhouse sees FY20 total capital expenditures of ~$160M 10/28/20 Texas Roadhouse reports Q3 EPS 42c, consensus 18c 08/03/20 Texas Roadhouse reports Q2 EPS (48c), consensus (63c) 08/03/20 Notable companies reporting after market close TXRH Texas Roadhouse $79.67 / +1.33 (+1.70%) 01/11/21 Zillow, Walgreens upgrades among today's top calls on Wall Street 11/23/20 Gap upgrade, Foot Locker downgrade among today's top calls on Wall Street 08/03/20 Fly Intel: After-Hours Movers 02/18/21 Texas Roadhouse - TXRH
Upgrade	Cheesecake Factory upgraded to Neutral from Underweight at JPMorgan » 05:38 01/25/21 01/25 05:38 01/25/21 05:38 CAKE Cheesecake Factory $42.36 / -0.62 (-1.44%) JPMorgan analyst John… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options CAKE Cheesecake Factory $42.36 / -0.62 (-1.44%) 12/04/20 Cheesecake Factory charged by SEC for misleading COVID-19 disclosures 10/29/20 Cheesecake Factory targets long-term unit growth of 3% 07/29/20 Cheesecake Factory says continues to perform well in the delivery category CAKE Cheesecake Factory $42.36 / -0.62 (-1.44%) 01/20/21 Deutsche Bank Cheesecake Factory price target raised to $47 from $40 at Deutsche Bank 01/19/21 Goldman Sachs Cheesecake Factory initiated with a Neutral at Goldman Sachs 01/07/21 Stephens Cheesecake Factory upgraded to Equal Weight on casual dining 'boom' at Stephens 01/07/21 Stephens Cheesecake Factory upgraded to Equal Weight from Underweight at Stephens CAKE Cheesecake Factory $42.36 / -0.62 (-1.44%) 10/29/20 Cheesecake Factory reports Q3 adjusted EPS (33c), consensus (42c) 07/29/20 Cheesecake Factory reports Q2 adjusted EPS (87c), consensus ($1.12) 07/29/20 Notable companies reporting after market close CAKE Cheesecake Factory $42.36 / -0.62 (-1.44%) 11/13/20 Disney upgrade among today's top calls on Wall Street 11/09/20 Biogen downgrade, Fisker initiation among today's top calls on Wall Street 07/29/20 Fly Intel: After-Hours Movers 02/17/21 Cheesecake Factory - CAKE CAKE Cheesecake Factory $42.36 / -0.62 (-1.44%) 08/28/20 Cheesecake Factory call volume above normal and directionally bullish

Downgrade	Sysco downgraded to Neutral from Overweight at JPMorgan » 05:38 01/25/21 01/25 05:38 01/25/21 05:38 SYY Sysco $75.21 / -1.73 (-2.25%) JPMorgan analyst John… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options SYY Sysco $75.21 / -1.73 (-2.25%) 01/14/21 Sysco announces 2025 seafood sustainability commitments 01/03/21 Fly Intel: Top five weekend stock stories 12/03/20 Sysco appoints Tom Peck as chief information, digital officer 11/20/20 Sysco awarded $136.23M Defense Logistics Agency contract SYY Sysco $75.21 / -1.73 (-2.25%) 12/16/20 Piper Sandler Sysco price target raised to $82 from $75 at Piper Sandler 12/14/20 JPMorgan Sysco price target raised to $76 from $72 at JPMorgan 12/02/20 Barclays Sysco price target raised to $65 from $62 at Barclays 11/11/20 Piper Sandler Sysco price target raised to $75 from $64 at Piper Sandler SYY Sysco $75.21 / -1.73 (-2.25%) 11/03/20 Sysco reports Q1 adj. EPS 34c, consensus 24c 11/02/20 Notable companies reporting before tomorrow's open 11/02/20 Notable companies reporting before tomorrow's open 08/11/20 Sysco reports Q4 adj. EPS (29c), consensus (30c) SYY Sysco $75.21 / -1.73 (-2.25%) 01/02/21 Coca-Cola, Disney among value stocks deserving a fresh look, Barron's says SYY Sysco $75.21 / -1.73 (-2.25%) 11/23/20 Fly Insider: Organogenesis, Estee Lauder among weeks notable insider trades 11/03/20 Fly Intel: Pre-market Movers 08/11/20 Fly Intel: Pre-market Movers 02/02/21 Sysco - SYY SYY Sysco $75.21 / -1.73 (-2.25%) 12/16/20 Sysco put volume heavy and directionally bearish 12/11/20 Sysco put volume heavy and directionally bearish 11/12/20 Sysco put volume heavy and directionally bearish 11/03/20 Early notable gainers among liquid option names on November 3rd
Downgrade	GameStop downgraded to Underperform from Outperform at Telsey Advisory » 05:37 01/25/21 01/25 05:37 01/25/21 05:37 GME GameStop $64.80 / +21.82 (+50.77%) Telsey Advisory analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options GME GameStop $64.80 / +21.82 (+50.77%) 01/22/21 GameStop extends rally as Citron stops commenting after 'mob' attack 01/22/21 GameStop trading resumes after volatility halt, shares up 52% to $65.56 01/22/21 GameStop trading resumes 01/22/21 GameStop trading halted, volatility trading pause GME GameStop $64.80 / +21.82 (+50.77%) 01/13/21 Standpoint Research GameStop downgraded to Hold from Buy at Standpoint Research 01/11/21 Benchmark Benchmark 'not surprised' by GameStop board change after 'disappointing' holiday 12/09/20 Benchmark GameStop price target lowered to $5 from $6 at Benchmark 12/04/20 Wedbush GameStop price target raised to $16 from $8 at Wedbush GME GameStop $64.80 / +21.82 (+50.77%) 12/08/20 GameStop reports Q3 adj. EPS (53c), consensus (85c) 12/08/20 GameStop reports Q3 EPS (29c), consensus (85c) 12/08/20 Notable companies reporting after market close 09/09/20 GameStop reports Q2 adj. EPS ($1.40), consensus ($1.13) GME GameStop $64.80 / +21.82 (+50.77%) 01/22/21 Citron Research no longer commenting on GameStop 01/19/21 Citron sees five reasons GameStop will trade 'back to $20 fast' 01/16/21 GameStop stock double last week, challenges remain, Barron's says 01/09/21 GameStop caught in vicious cycle, Barron's says GME GameStop $64.80 / +21.82 (+50.77%) 01/22/21 Fly Intel: Wall Street's top stories for Friday 01/19/21 Game On: An exclusive talk with The Game Bakers' Emeric Thoa 01/12/21 Game On: Roblox files for direct listing as GameStop adds new directors 01/05/21 Game On: Nintendo buys 'Luigi's Mansion 3' developer Next Level Games GME GameStop $64.80 / +21.82 (+50.77%) 01/19/21 Largest borrow rate increases among liquid names 01/14/21 Notable open interest changes for January 14th 01/13/21 GameStop call volume above normal and directionally bullish 01/13/21 Largest borrow rate increases among liquid names
Upgrade	Sika upgraded to Buy from Hold at HSBC » 05:36 01/25/21 01/25 05:36 01/25/21 05:36 SXYAY Sika $0.00 / + (+0.00%) HSBC analyst John… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research SXYAY Sika $0.00 / + (+0.00%) 01/14/21 Berenberg Sika price target raised to CHF 265 from CHF 245 at Berenberg 01/13/21 Barclays Sika price target raised to CHF 285 from CHF 270 at Barclays 01/06/21 Morgan Stanley Sika price target raised to CHF 295 from CHF 293 at Morgan Stanley 12/18/20 Baader Helvea Sika upgraded to Add from Reduce at Baader Helvea
Upgrade	Constellation upgraded to Outperform from Market Perform at BMO Capital » 05:36 01/25/21 01/25 05:36 01/25/21 05:36 CNST Constellation Pharmaceuticals $34.06 / -0.39 (-1.13%) BMO Capital analyst Do… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events CNST Constellation Pharmaceuticals $34.06 / -0.39 (-1.13%) 01/07/21 Constellation Pharmaceuticals appoints Brendan Delaney as CCO 12/06/20 Constellation Pharmaceuticals provides update of MANIFEST study for CPI-0610 10/29/20 Constellation expects cash to fund operations in mid-2023 08/05/20 Constellation Pharmaceuticals announces 2020 milestones CNST Constellation Pharmaceuticals $34.06 / -0.39 (-1.13%) 10/30/20 JPMorgan Constellation added to Analyst Focus List at JPMorgan 09/08/20 Oppenheimer Constellation Pharmaceuticals downgraded to Perform at Oppenheimer 09/08/20 Oppenheimer Constellation downgraded to Perform from Outperform at Oppenheimer 09/03/20 Brookline Constellation Pharmaceuticals initiated with a Buy at Brookline CNST Constellation Pharmaceuticals $34.06 / -0.39 (-1.13%) 10/29/20 Constellation Pharmaceuticals reports Q3 EPS (71c), consensus (68c) 08/05/20 Constellation Pharmaceuticals reports Q1 EPS (70c), consensus (63c) 17 Jun 03/01/21 41st Annual Healthcare Virtual Conference
Downgrade	Alnylam downgraded to Market Perform from Outperform at BMO Capital » 05:36 01/25/21 01/25 05:36 01/25/21 05:36 ALNY Alnylam $172.42 / +5.75 (+3.45%) BMO Capital analyst Do… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events ALNY Alnylam $172.42 / +5.75 (+3.45%) 01/07/21 Alnylam trading resumes 01/07/21 Alnylam announces HELIOS-A study met primary, both secondary endpoints 01/07/21 Alnylam trading halted, news pending 12/21/20 Alnylam appoints Tolga Tanguler to Chief Commercial Officer role ALNY Alnylam $172.42 / +5.75 (+3.45%) 01/13/21 Cowen Alnylam price target raised to $197 from $154 at Cowen 01/11/21 B. Riley Securities Dicerna price target raised to $37 from $30 at B. Riley Securities 12/21/20 RBC Capital Alnylam price target lowered to $144 from $150 at RBC Capital 12/20/20 Piper Sandler Inclisiran CRL 'a surprise,' not big negative for Alnylam, says Piper Sandler ALNY Alnylam $172.42 / +5.75 (+3.45%) 11/05/20 Alnylam reports Q3 EPS ($1.58), consensus ($1.66) 08/06/20 Alnylam reports Q2 EPS ($1.67), consensus ($1.74) ALNY Alnylam $172.42 / +5.75 (+3.45%) 11/23/20 Alnylam gets FDA approval for Oxlumo, Bloomberg reports ALNY Alnylam $172.42 / +5.75 (+3.45%) 08/11/20 Honeywell downgrade among today's top calls on Wall Street 03/01/21 41st Annual Healthcare Virtual Conference

Hot Stocks	Genentech announces topline results from TENAYA, LUCERNE studies of faricimab » 05:35 01/25/21 01/25 05:35 01/25/21 05:35 RHHBY Roche $0.00 / + (+0.00%) Genentech, a member of… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events RHHBY Roche $0.00 / + (+0.00%) 01/21/21 Roche announces FDA acceptance of Genentech Esbriet sNDA 01/12/21 Roche confirms U.S to buy additional doses of Regeneron's Cov-19 cocktail 01/07/21 Roche granted FDA orphan drug status for Atezolizumab in esophageal cancer 01/06/21 Pluristem appoints Maital Shemesh-Rasmussen, Rami Levi to board RHHBY Roche $0.00 / + (+0.00%) 01/22/21 Barclays Roche price target lowered to CHF 375 from CHF 395 at Barclays 01/15/21 Deutsche Bank Roche initiated with a Hold at Deutsche Bank 01/12/21 UBS Roche price target lowered to CHF 355 from CHF 365 at UBS 01/11/21 Berenberg Roche price target lowered to CHF 325 from CHF 350 at Berenberg RHHBY Roche $0.00 / + (+0.00%) 10/27/20 Oncolytics announces new GI cancer study using 10/15/20 Roche confirms outlook for 2020 based on assessment of COVID-19 10/15/20 Roche reports 9 months group sales CHF43.98B vs. CHF46.07B last year 09/11/20 Genentech: data shows Ocrevus 'highly effective' treatment option in RRMS RHHBY Roche $0.00 / + (+0.00%) 12/23/20 Judge rules against White House drug pricing rule, Reuters says 11/23/20 EU seeks easier access to generic medicines, Reuters says 11/20/20 Trump to release new rules aimed at lowering drug prices, WSJ reports 11/17/20 Regeneron says Roche completed early tests to make COVID drug, Reuters says RHHBY Roche $0.00 / + (+0.00%) 12/26/20 Week in review: How Trump's policies moved stocks 11/30/20 Fly Intel: Wall Street's top stories for Monday 11/30/20 Fly Intel: Wall Street's top stories at midday 11/21/20 Week in review: How Trump's policies moved stocks 01/28/21 IASLC Virtual World Conference on Lung Cancer 03/01/21 41st Annual Healthcare Virtual Conference 03/02/21 2021 London Global Healthcare Virtual Conference 02/04/21 Roche - RHHBY
Downgrade	Kodiak Sciences downgraded to Market Perform from Outperform at BMO Capital » 05:35 01/25/21 01/25 05:35 01/25/21 05:35 KOD Kodiak Sciences $164.33 / +6.31 (+3.99%) BMO Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly KOD Kodiak Sciences $164.33 / +6.31 (+3.99%) 11/16/20 Kodiak Sciences completes enrollment of DAZZLE study of KSI-301 10/05/20 Kodiak Sciences: First patients treated in Phase 3 Studies of KSI-301 KOD Kodiak Sciences $164.33 / +6.31 (+3.99%) 12/17/20 Berenberg Kodiak Sciences initiated with a Buy at Berenberg 12/15/20 UBS Kodiak Sciences initiated with a Buy at UBS 12/11/20 Citi Kodiak Sciences initiated with a Neutral at Citi 11/30/20 Fly Intel: Top five analyst downgrades KOD Kodiak Sciences $164.33 / +6.31 (+3.99%) 11/09/20 Kodiak Sciences reports Q3 EPS (80c), consensus (67c) 08/10/20 Kodiak Sciences reports Q2 EPS (58c), consensus (66c) 18 Nov KOD Kodiak Sciences $164.33 / +6.31 (+3.99%) 11/16/20 Fly Intel: After-Hours Movers 09/14/20 Fly Insider: Karuna, DexCom among weeks notable insider trades 08/24/20 Fly Insider: Kodiak, Camping World among week's notable insider trades
Upgrade	Regeneron upgraded to Outperform from Market Perform at BMO Capital » 05:34 01/25/21 01/25 05:34 01/25/21 05:34 REGN Regeneron $537.77 / +2.465 (+0.46%) BMO Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options REGN Regeneron $537.77 / +2.465 (+0.46%) 01/13/21 Regeneron awarded $2.625B government contract 01/12/21 Roche confirms U.S to buy additional doses of Regeneron's Cov-19 cocktail 01/12/21 Regeneron says HHS, DOD to purchase more COVID-19 antibody cocktail doses 01/07/21 Intellia to nominate at least one new development candidate in 2021 REGN Regeneron $537.77 / +2.465 (+0.46%) 01/14/21 Citi Regeneron price target raised to $584 from $575 at Citi 01/13/21 Benchmark Regeneron upgraded to Buy on COVID-19 cocktail developments at Benchmark 01/13/21 Benchmark Regeneron upgraded to Buy from Hold at Benchmark 01/08/21 Citi Regeneron upgraded to Buy from Neutral at Citi REGN Regeneron $537.77 / +2.465 (+0.46%) 11/05/20 Regeneron reports Q3 EPS $8.36, consensus $7.13 11/04/20 Notable companies reporting before tomorrow's open 11/04/20 Notable companies reporting before tomorrow's open 08/05/20 Regeneron reports Q2 EPS $7.16, consensus $5.98 27 May REGN Regeneron $537.77 / +2.465 (+0.46%) 12/30/20 Fresenius to administer Lilly, Regeneron COVID antibody drugs, Reuters says 12/04/20 Regeneron must face DOJ suit citing kickbacks, Bloomberg says 11/17/20 Regeneron says Roche completed early tests to make COVID drug, Reuters says 10/13/20 FDA flags quality control at Lilly factory making COVID drug, Reuters says REGN Regeneron $537.77 / +2.465 (+0.46%) 01/12/21 Fly Intel: After-Hours Movers 11/23/20 Fly Intel: Wall Street's top stories for Monday 11/23/20 Fly Intel: Wall Street's top stories at midday 11/23/20 Fly Intel: Pre-market Movers 03/01/21 41st Annual Healthcare Virtual Conference 02/05/21 Regeneron - REGN 02/11/21 PDUFA Date for Evinacumab REGN Regeneron $537.77 / +2.465 (+0.46%) 01/13/21 Early notable gainers among liquid option names on January 13th 12/18/20 Early notable gainers among liquid option names on December 18th 11/06/20 Regeneron put volume heavy and directionally bearish 10/08/20 Unusually active option classes on open October 8th
Upgrade	American Eagle upgraded to Outperform from Sector Perform at RBC Capital » 05:33 01/25/21 01/25 05:33 01/25/21 05:33 AEO American Eagle $24.28 / +0.35 (+1.46%) RBC Capital analyst Kate… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options AEO American Eagle $24.28 / +0.35 (+1.46%) 01/21/21 American Eagle targeting 600-700 AE stores in U.S. and Canada 01/21/21 American Eagle announces long term growth targets 12/03/20 American Eagle reinstates 13.75c per share quarterly dividend 11/24/20 American Eagle says dividend suspension remains in place AEO American Eagle $24.28 / +0.35 (+1.46%) 01/22/21 Jefferies American Eagle price target raised to $30 after investor day at Jefferies 01/22/21 B. Riley Securities American Eagle price target raised to $30 from $28 at B. Riley Securities 01/22/21 BMO Capital American Eagle price target raised to $26 from $19 at BMO Capital 01/22/21 Deutsche Bank American Eagle price target raised to $29 from $25 at Deutsche Bank AEO American Eagle $24.28 / +0.35 (+1.46%) 01/21/21 American Eagle sees Q4 revenue down low single digits, consensus $1.31B 11/24/20 American Eagle reports Q3 EPS 35c, consensus 34c 11/24/20 Notable companies reporting after market close 09/09/20 American Eagle reports Q2 adj. EPS (3c), consensus (16c) AEO American Eagle $24.28 / +0.35 (+1.46%) 11/05/20 American Eagle partners with Disney for holiday collaboration, WWD reports 09/03/20 American Eagle launches Snapchat dance challenge, WWD reports AEO American Eagle $24.28 / +0.35 (+1.46%) 11/24/20 Fly Intel: After-Hours Movers 10/14/20 Microsoft resumption, Nio upgrade among top calls on Wall Street 10/07/20 Fly Intel: Pre-market Movers 07/30/20 Walmart, Target initiations among today's top calls on Wall Street AEO American Eagle $24.28 / +0.35 (+1.46%) 12/29/20 American Eagle call volume above normal and directionally bullish 11/24/20 American Eagle options imply 10.4% move in share price post-earnings 10/29/20 American Eagle put volume heavy and directionally bearish 10/19/20 American Eagle put volume heavy and directionally bearish
Downgrade	Keysight Technologies downgraded to Hold from Buy at Deutsche Bank » 05:33 01/25/21 01/25 05:33 01/25/21 05:33 KEYS Keysight Technologies $145.19 / -1.49 (-1.02%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options KEYS Keysight Technologies $145.19 / -1.49 (-1.02%) 01/19/21 Keysight's edge-to-core portfolio selected by Radisys 11/24/20 Keysight Technologies CEO sells 103.5K shares of common stock 11/18/20 Keysight Technologies authorizes up to $750M share repurchase program 10/01/20 Keysight Technologies announces Satish Dhanasekaran as COO, CTO to retire KEYS Keysight Technologies $145.19 / -1.49 (-1.02%) 01/22/21 Citi Keysight Technologies price target raised to $175 from $130 at Citi 01/15/21 UBS Keysight Technologies price target raised to $170 from $145 at UBS 01/14/21 Barclays Keysight Technologies price target raised to $161 from $135 at Barclays 11/19/20 Baird Keysight Technologies price target raised to $126 from $112 at Baird KEYS Keysight Technologies $145.19 / -1.49 (-1.02%) 11/18/20 Keysight Technologies sees Q1 adjusted EPS $1.32-$1.38, consensus $1.25 11/18/20 Keysight Technologies reports Q4 adjusted EPS $1.62, consensus $1.46 08/20/20 Keysight Technologies sees Q4 adjusted EPS $1.42-$1.48, consensus $1.24 08/20/20 Keysight Technologies reports Q3 adjusted EPS $1.19, consensus 83c KEYS Keysight Technologies $145.19 / -1.49 (-1.02%) 08/20/20 Fly Intel: After-Hours Movers 08/13/20 Fly Intel: Wall Street's top stories for Thursday 08/13/20 Fly Intel: Wall Street's top stories at midday KEYS Keysight Technologies $145.19 / -1.49 (-1.02%) 08/20/20 Keysight Technologies options imply 5.6% move in share price post-earnings

Downgrade	Hikma Pharmaceuticals downgraded to Hold from Buy at Peel Hunt » 05:32 01/25/21 01/25 05:32 01/25/21 05:32 HKMPF Hikma Pharmaceuticals $0.00 / + (+0.00%) Peel Hunt analyst Amy… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research HKMPF Hikma Pharmaceuticals $0.00 / + (+0.00%) 12/17/20 Hikma Pharmaceuticals launches generic Advair Diskus following FDA approval 11/05/20 Hikma Pharmaceuticals launches Icosapent Ethyl capsules in the U.S. 09/03/20 Hikma says 'working towards a launch' of generic version of Amarin's Vascepa 09/03/20 Hikma reports 'favorable court ruling' for generic Vascepa HKMPF Hikma Pharmaceuticals $0.00 / + (+0.00%) 01/05/21 Citi Underlying trends for Hikma point to upside risks, says Citi 11/24/20 JPMorgan Hikma Pharmaceuticals price target raised to 3,000 GBp from 2,400 GBp at JPMorgan 09/22/20 Morgan Stanley Hikma Pharmaceuticals downgraded to Equal Weight from Overweight at Morgan Stanley 09/22/20 Morgan Stanley Hikma downgraded to Equal Weight from Overweight at Morgan Stanley
Earnings	Philips reports Q4 adjusted EPS EUR 0.94 vs. EUR 0.83 last year » 05:32 01/25/21 01/25 05:32 01/25/21 05:32 PHG Philips $55.60 / +0.22 (+0.40%) Reports Q4 revenue EUR 6B… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events PHG Philips $55.60 / +0.22 (+0.40%) 05:22 Today Philips, Rennes University Hospital announce five-year partnership 05:13 Today Philips, Vithas Group enter five-year innovation and collaboration agreement 01/19/21 Philips to acquire Capsule Technologies for $635M in cash, sees accretion 01/14/21 Philips. Merck partner on personalized fertility treatment solutions PHG Philips $55.60 / +0.22 (+0.40%) 01/20/21 Berenberg Philips price target raised to EUR 50 from EUR 49 at Berenberg 01/19/21 JPMorgan Philips price target raised to EUR 44 from EUR 39.40 at JPMorgan 11/12/20 Berenberg Philips price target raised to EUR 49 from EUR 46 at Berenberg 10/29/20 Morgan Stanley Philips price target raised to EUR 50 from EUR 48 at Morgan Stanley PHG Philips $55.60 / +0.22 (+0.40%) 10/19/20 Philips reports Q3 adj. EPS EUR 0.60 vs. EUR 0.46 last year PHG Philips $55.60 / +0.22 (+0.40%) 01/05/21 Philips shortlists Asian suitors in home appliance unit sale, Bloomberg says PHG Philips $55.60 / +0.22 (+0.40%) 12/18/20 Fly Intel: Wall Street's top stories for Friday 12/18/20 Fly Intel: Wall Street's top stories at midday 10/19/20 Fly Intel: Pre-market Movers 09/05/20 Week in review: How Trump's policies moved stocks 03/02/21 2021 London Global Healthcare Virtual Conference 16:00 Today Philips - PHG
Downgrade	Silence Therapeutics downgraded to Hold from Buy at Peel Hunt » 05:31 01/25/21 01/25 05:31 01/25/21 05:31 SLNCF Silence Therapeutics $0.00 / + (+0.00%) Peel Hunt analyst Miles… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings SLNCF Silence Therapeutics $0.00 / + (+0.00%) 01/06/21 Silence Therapeutics appoints Craig Tooman as CFO 01/06/21 Silence Therapeutics appoints Michael Davidson to board of directors 11/16/20 Silence Therapeutics presents pre-clinical data for SLN360 10/08/20 Silence Therapeutics initiates search for CFO SLNCF Silence Therapeutics $0.00 / + (+0.00%) 08/24/20 H.C. Wainwright Silence Therapeutics initiated with a Buy at H.C. Wainwright SLNCF Silence Therapeutics $0.00 / + (+0.00%) 09/14/20 Silence Therapeutics reports six months EPS (13.7p) vs. (11.5p) last year
Downgrade	Vectura Group downgraded to Hold from Buy at Peel Hunt » 05:31 01/25/21 01/25 05:31 01/25/21 05:31 VEGPF Vectura Group $0.00 / + (+0.00%) Peel Hunt analyst Amy … Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings VEGPF Vectura Group $0.00 / + (+0.00%) 01/22/21 Citi Vectura Group downgraded to Neutral from Buy at Citi 09/23/20 JPMorgan Vectura Group price target raised to 130 GBp from 115 GBp at JPMorgan VEGPF Vectura Group $0.00 / + (+0.00%) 09/15/20 Vectura Group reports 1H20 EPS 0.3p vs. (2.0p) last year
Downgrade	Arjo downgraded to Hold from Buy at Pareto » 05:29 01/25/21 01/25 05:29 01/25/21 05:29 ARRJF Arjo $0.00 / + (+0.00%) Pareto analyst Peter… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research ARRJF Arjo $0.00 / + (+0.00%) 01/20/21 Nordea Arjo downgraded to Sell from Hold at Nordea

Downgrade	Centennial Resource Development downgraded to Hold from Buy at Stifel » 05:29 01/25/21 01/25 05:29 01/25/21 05:29 CDEV Centennial Resource Development $2.52 / +0.25 (+11.04%) Stifel analyst Derrick… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings On The Fly CDEV Centennial Resource Development $2.52 / +0.25 (+11.04%) 11/30/20 MKM Partners Centennial Resource Development downgraded to Neutral from Buy at MKM Partners 11/30/20 MKM Partners Centennial Resource Development downgraded to Neutral from Buy at MKM Partners 10/22/20 Piper Sandler Centennial Resource upgraded to Neutral from Underweight at Piper Sandler 09/14/20 Wells Fargo Centennial Resource Development downgraded to Underweight from Equal Weight at Wells Fargo CDEV Centennial Resource Development $2.52 / +0.25 (+11.04%) 11/02/20 Centennial Resource Development reports Q3 EPS (19c), consensus (19c) 08/03/20 Centennial Resource Development reports Q2 EPS 2c, consensus (28c) CDEV Centennial Resource Development $2.52 / +0.25 (+11.04%) 11/30/20 Fly Intel: Pre-market Movers
Downgrade	QEP Resources downgraded to Hold from Buy at Stifel » 05:28 01/25/21 01/25 05:28 01/25/21 05:28 QEP QEP Resources $3.14 / +0.135 (+4.49%) , FANG Diamondback Energy $63.75 / +2.97 (+4.89%) Stifel analyst Derrick… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options QEP FANG QEP QEP Resources $3.14 / +0.135 (+4.49%) 01/14/21 QEP Resources board declares special stock dividend of 5% per share 12/21/20 Diamondback Energy says QEP Resources acquisition 'checks every box' of strategy 12/21/20 Diamondback Energy to acquire QEP Resources in $2.2B all-stock transaction 12/21/20 Diamondback Energy to acquire QEP Resources in all-stock transaction FANG Diamondback Energy $63.75 / +2.97 (+4.89%) 12/21/20 Diamondback Energy says QEP Resources acquisition 'checks every box' of strategy 12/21/20 Diamondback Energy to acquire QEP Resources in $2.2B all-stock transaction 12/21/20 Diamondback Energy to acquire QEP Resources in all-stock transaction 12/21/20 Diamondback Energy sees Guidon acquisition accretive on key 2021 metrics QEP FANG QEP QEP Resources $3.14 / +0.135 (+4.49%) 12/28/20 Northland Diamondback Energy price target raised to $60 from $50 at Northland 12/22/20 Stephens Diamondback Energy price target raised to $67 from $56 at Stephens 12/22/20 Susquehanna Diamondback Energy deal strengthens free cash flow, says Susquehanna 12/08/20 JPMorgan QEP Resources upgraded to Overweight from Neutral at JPMorgan FANG Diamondback Energy $63.75 / +2.97 (+4.89%) 01/20/21 Cowen Diamondback Energy price target raised to $75 from $60 at Cowen 01/14/21 Barclays Diamondback Energy price target raised to $68 from $46 at Barclays 01/14/21 RBC Capital Diamondback Energy price target raised to $72 from $67 at RBC Capital 01/13/21 JPMorgan JPMorgan announces top 10 energy picks for 2021 QEP FANG QEP QEP Resources $3.14 / +0.135 (+4.49%) 10/28/20 QEP Resources reports Q3 EPS (20c), consensus 2c 07/29/20 QEP Resources reports Q2 adj. EPS (6c), consensus (3c) FANG Diamondback Energy $63.75 / +2.97 (+4.89%) 11/02/20 Diamondback Energy reports Q3 EPS 62c, consensus 37c 08/03/20 Diamondback Energy reports Q2 EPS 15c, consensus 1c QEP FANG QEP QEP Resources $3.14 / +0.135 (+4.49%) 12/02/20 QEP Resources seeing inbound M&A interest, Debtwire says FANG Diamondback Energy $63.75 / +2.97 (+4.89%) 12/02/20 QEP Resources seeing inbound M&A interest, Debtwire says 11/19/20 Betaville speculates on takeover interest in Diamondback Energy, Bloomberg says 10/27/20 President Trump weighing executive order to show support for fracking, WSJ says FANG FANG Diamondback Energy $63.75 / +2.97 (+4.89%) 12/11/20 Airline changes, another Tesla downgrade among today's top calls on Wall Street 10/31/20 Week in review: How Trump's policies moved stocks 03/01/21 26th Annual Energy Virtual Summit 02/23/21 Diamondback Energy - FANG QEP FANG QEP QEP Resources $3.14 / +0.135 (+4.49%) 07/29/20 QEP Resources options imply 35.4% move in share price post-earnings FANG Diamondback Energy $63.75 / +2.97 (+4.89%) 11/17/20 Diamondback Energy call volume above normal and directionally bullish 10/28/20 Diamondback Energy call volume above normal and directionally bullish
Upgrade	Salesforce upgraded to Hold from Sell at Loop Capital » 05:27 01/25/21 01/25 05:27 01/25/21 05:27 CRM Salesforce $225.69 / +3.48 (+1.57%) Loop Capital analyst Yun… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options CRM Salesforce $225.69 / +3.48 (+1.57%) 01/14/21 Microsoft, Oracle, Salseforce, others form Vaccination Credential Initiative 01/11/21 IBM acquires 7Summits, terms not disclosed 12/01/20 Salesforce CEO says fundamental customer experience changes with Slack 12/01/20 Salesforce falls 4% to $231.43 after Q3 earnings, guidance, confirmed Slack deal CRM Salesforce $225.69 / +3.48 (+1.57%) 01/21/21 Goldman Sachs Salesforce initiated with a Buy at Goldman Sachs 01/15/21 Credit Suisse Salesforce price target raised to $260 from $245 at Credit Suisse 01/11/21 Piper Sandler Salesforce downgraded to Neutral from Overweight at Piper Sandler 12/17/20 Rosenblatt LivePerson initiated with a Buy at Rosenblatt CRM Salesforce $225.69 / +3.48 (+1.57%) 12/01/20 Salesforce initiates FY22 revenue view of $25.45B-$25.55B, consensus $24.5B 12/01/20 Salesforce initiates Q1 revenue view of $5.68B-$5.715B 12/01/20 Salesforce raises FY21 EPS view to $4.62-$4.63 from $3.72-3.74 12/01/20 Salesforce sees Q4 EPS 73c-74c, consensus 86c CRM Salesforce $225.69 / +3.48 (+1.57%) 12/05/20 Salesforce paying huge price for Slack, deal might not work, Barron's says 11/30/20 Salesforce deal for Slack coming tomorrow at premium, CNBC reports 11/30/20 Salesforce to acquire Slack at premium to current share price, CNBC reports 11/30/20 Salesforce acquisition of Slack to be announced tomorrow, CNBC reports CRM Salesforce $225.69 / +3.48 (+1.57%) 12/16/20 Microsoft reinstatement, Spotify downgrade among top calls on Wall Street 12/02/20 Fly Intel: Wall Street's top stories for Wednesday 12/02/20 #SocialStocks: Analysts unimpressed with Slack deal 12/02/20 Fly Intel: What to watch in Snowflake earnings report CRM Salesforce $225.69 / +3.48 (+1.57%) 01/22/21 Early notable gainers among liquid option names on January 22nd 01/22/21 Unusually active option classes on open January 22nd 12/03/20 Notable open interest changes for December 3rd 12/01/20 Salesforce options imply 9.1% move in share price post-earnings
Upgrade	Hannover Re upgraded to Buy from Hold at Societe Generale » 05:26 01/25/21 01/25 05:26 01/25/21 05:26 HVRRY Hannover Re $0.00 / + (+0.00%) Societe Generale analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research HVRRY Hannover Re $0.00 / + (+0.00%) 01/05/21 Deutsche Bank Hannover Re upgraded to Buy from Hold at Deutsche Bank 12/02/20 Morgan Stanley Hannover Re upgraded to Overweight from Equal Weight at Morgan Stanley 11/24/20 Barclays Hannover Re price target raised to EUR 129.20 from EUR 126.20 at Barclays 11/18/20 Societe Generale Hannover Re downgraded to Hold from Buy at Societe Generale
Hot Stocks	Pfizer, Merck announce EC approval of Bavencio for UC patients » 05:26 01/25/21 01/25 05:26 01/25/21 05:26 PFE Pfizer $36.54 / +0.05 (+0.14%) , MRK Merck $80.96 / -0.19 (-0.23%) EMD Serono, the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options PFE MRK PFE Pfizer $36.54 / +0.05 (+0.14%) 01/22/21 Pfizer, BioNTech reach agreement with COVAX for advance purchase of vaccine 01/22/21 Coty promotes Stephane Delbos to chief procurement officer 01/21/21 ViiV Healthcare announces FDA approval of Cabenuva 01/21/21 Cerevel Therapeutics appoints Deval Patrick, Deborah Baron to board MRK Merck $80.96 / -0.19 (-0.23%) 01/20/21 Merck granted FDA approval of Verquvo for cardiosvacular risk reduction 01/19/21 Cocrystal Pharma completes research obligations under Merck agreement 01/19/21 Atea Pharmaceuticals appoints Jayanthi Wolf as SVP, regulatory affairs 01/14/21 Philips. Merck partner on personalized fertility treatment solutions PFE MRK PFE Pfizer $36.54 / +0.05 (+0.14%) 01/14/21 Morgan Stanley 80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley 01/14/21 Oppenheimer Essa Pharma price target raised to $20 from $9 at Oppenheimer 01/05/21 Argus Viatris initiated with a Hold at Argus 12/31/20 Ladenburg UK study supports potential of Arcturus COVID vaccine candidate, says Ladenburg MRK Merck $80.96 / -0.19 (-0.23%) 01/21/21 Wedbush Scholar Rock price target raised to $66 from $47 at Wedbush 01/20/21 William Blair Exelixis selloff on competitive concerns an 'overreaction,' says William Blair 01/20/21 Citi Citi opens 'negative Catalyst Watch' on Bristol-Myers 01/06/21 Citi Citi opens 'positive catalyst watch' on Merck PFE MRK PFE Pfizer $36.54 / +0.05 (+0.14%) 01/12/21 Pfizer sees FY21 EPS around $3.00-$3.10, consensus $3.07 10/27/20 Pfizer sees FY20 Upjohn revenue $8B-$8.5B, adjusted EBITDA $3.8B-$4.2B 10/27/20 Pfizer sees FY20 adjusted EPS for New Pfizer $2.28-$2.38, revenue $40.8B-$42.4B 10/27/20 Pfizer narrows FY20 adjusted EPS view to $2.88-$2.93 from $2.85-$2.95 MRK Merck $80.96 / -0.19 (-0.23%) 10/27/20 Merck raises FY20 adjusted EPS view to $5.91-$6.01 from $5.63-$5.78 10/27/20 Merck reports Q3 adjusted EPS $1.74, consensus $1.43 10/26/20 Notable companies reporting before tomorrow's open 10/26/20 Notable companies reporting before tomorrow's open PFE MRK PFE Pfizer $36.54 / +0.05 (+0.14%) 01/21/21 Pfizer slashes vaccine deliveries to some EU countries by 50%, Reuters reports 01/21/21 Pfizer and BioNTech agree to supply vaccine to WHO co-led effort, Reuters says 01/20/21 Hong Kong set to approve COVID vaccine by Pfizer/BioNTech, SCMP says 01/20/21 Japan inks deal with Pfizer for COVID vaccine for 72M people, Nikkei reports MRK Merck $80.96 / -0.19 (-0.23%) 12/23/20 Judge rules against White House drug pricing rule, Reuters says 12/19/20 Alphabet, Apple among Barron's 10 Top stocks for 2021, Barron's says 11/23/20 EU seeks easier access to generic medicines, Reuters says 11/20/20 Trump to release new rules aimed at lowering drug prices, WSJ reports PFE MRK PFE Pfizer $36.54 / +0.05 (+0.14%) 01/12/21 Fly Intel: Wall Street's top stories for Tuesday 01/12/21 Fly Intel: Wall Street's top stories at midday 01/08/21 Fly Intel: Wall Street's top stories for Friday 01/08/21 Fly Intel: Wall Street's top stories at midday MRK Merck $80.96 / -0.19 (-0.23%) 12/26/20 Week in review: How Trump's policies moved stocks 12/02/20 Fly Intel: Wall Street's top stories at midday 12/02/20 Fly Intel: Pre-market Movers 11/23/20 Fly Intel: Wall Street's top stories for Monday 02/08/21 17th Annual Virtual WORLDSymposium 2021 03/01/21 41st Annual Healthcare Virtual Conference 02/02/21 Pfizer - PFE 02/04/21 Merck - MRK 02/09/21 Oncologic Drugs Advisory Committee Virtual Meeting 04/13/21 PDUFA Date for Keytrude w/Chemotherapy 07/18/21 PDUFA Date for V114 12/29/21 PDUFA Date for Lorbrena (Lorlatinib) April 2021 PFE MRK PFE Pfizer $36.54 / +0.05 (+0.14%) 12/15/20 Notable open interest changes for December 15th 12/14/20 Unusually active option classes on open December 14th 12/11/20 Unusually active option classes on open December 11th 12/11/20 Notable open interest changes for December 11th MRK Merck $80.96 / -0.19 (-0.23%) 12/23/20 Merck call volume above normal and directionally bullish 10/20/20 Merck put volume heavy and directionally bearish 08/06/20 Unusually active option classes on open August 6th 08/05/20 Merck call volume above normal and directionally bullish

Events

Earnings calls, analyst events, roadshows and more

Today at 08:30

Chicago Fed National Activity Index: December 2020 Government Event
Today at 08:30

Chicago Fed National Activity Index--3 Month Moving Average: December 2020 Government Event
CADE
Today at 08:30

Cadence Bancorp - CADE Conference Calls
SMG
Today at 09:00

The Scotts Miracle-Gro Company Firm Sponsored Meetings
KMB
Today at 10:00

Kimberly-Clark - KMB Conference Calls
OFG
Today at 10:00

OFG Bancorp - OFG Conference Calls
Today at 10:30

Dallas Fed Manufacturing Survey Production Index: January 2021 Government Event
Today at 10:30

Dallas Fed Manufacturing Survey--General Activity Index: January 2021 Government Event
FRBK
Today at 11:00

Republic First Bancorp - FRBK Conference Calls
CBU
Today at 11:00

Community Bank System - CBU Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	AGFY X AGFY Agrify IPO Managers: Maxim & Roth Capital $8.00-10.00 2.8M Shares
Tues	SHLS X SHLS Shoals Technologies IPO Managers: Goldman Sachs, JPMorgan, Guggenheim, UBS, Morgan Stanley, Barclays & Credit Suisse, Cowen, Oppenheimer $19.00-21.00 50M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	OCDX X OCDX Ortho Clinical IPO Managers: JPMorgan, BofA, Goldman Sachs, Barclays & Morgan Stanley, Citi, Credit Suisse, UBS, Evercore ISI, Piper Sandler, ING Bank, Macquarie, Nomura, TCG Capital Markets, Drexel Hamilton, H.C. Wainwright, Ramirez, Seibert Williams $20.00-23.00 70M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VINP X VINP Vinci Partners Investments IPO Managers: JPMorgan, Goldman Sachs & BTG Pactual, Itau BBA, BofA, Credit Suisse, UBS $16.00-18.00 13.873M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial XM X XM Qualtrics IPO Managers: Morgan Stanley & JPMorgan, BofA, Barclays, Deutsche Bank, Goldman Sachs, HSBC, Citi, BMO Capital, Truist, Canaccord, Evercore ISI, JPMorgan, Oppenheimer, Piper Sandler, Raymond James, William Blair, Loop Capital, RMRZ, SEEL $22.00-26.00 49.2M Shares ZIM X ZIM ZIM Integrated IPO Managers: Citi, Goldman Sachs & Barclays, Jefferies, Clarksons Platou $16.00-19.00 17.5M Shares
Thurs	SEGR X SEGR Southeastern Grocers IPO Managers: BofA & Goldman Sachs, Deutsche Bank, BMO Capital, Truist, Wells Fargo $14.00-16.00 8.9M Shares
Fri	No deals

View All Syndicate Announcements »

Freeport McMoRan says Cerro Verde temporarily shifts to care, maintenance status

TODAY'S FREE FLY STORIES

Get Full Fly Access